Showing 1951-1960 of 7783 results for "".
DermWireTV: COVID Vaccine Approved; Update on Delta and Dermatology Practice
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-vaccine-approved-update-on-delta-and-dermatology-practice/19998/FDA approval of Pfizer-BioNTech’s Comirnaty COVID-19 Vaccine comes as Coronavirus case rates surge across the US. We take a look at potential implications for dermatology of the Delta variant spread.Connecting with Industry
https://practicaldermatology.com/series/dermatology-education-foundation/connecting-with-industry/19990/Beyond offering attendees a chance to network with one another, Dermatology Education Foundations meetings are a chance for attendees and industry to interact. Wendy Cantrell, CRNP, DNP says it's great to learn from these knowledgeable representatives, plus an excellent time to tell them how they caA Resurgence: Ablative Resurfacing
https://practicaldermatology.com/conferences/aad-summer-2021/a-resurgence-ablative-resurfacing/19977/Mask mandates, social distancing, and increased tolerance for downtime seem to have led to an uptick in ablative resurfacing. These procedures can offer dramatic results, but Arisa Ortiz, MD says it's important to select the right patients. Plus, she offers tips for post-care counseling to manage paDermWireTV: Galderma Gets Cheeky, COVID Vax & Skin, AKN Classification
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-gets-cheeky-covid-vax-skin-akn-classification/19955/Only a small percentage of patients have skin reactions to COVID-19 vaccines, but true allergic reactions must be identified. FDA approves Restylane Contour from Galderma. New classification may aid treatment selection or acne keloidalis.Removing Obstacles to Dermatologic Care for LGBTQ/GSM Patients
https://practicaldermatology.com/topics/practice-management/removing-obstacles-to-dermatologic-care-for-lgbtqgsm-patients/19935/Members of gender and sexual minority groups may feel less comfortable seeking healthcare than their non-LGBTQ/GSM counterparts. Klint Peebles, MD addresses some of the barriers to access and offers strategies for building more inclusive and welcoming dermatology practices.Coding for SRT: An Update
https://practicaldermatology.com/topics/skin-cancer-photoprotection/coding-for-srt-an-update/19908/Superficial radiation therapy (SRT) is an important option for many patients with skin cancers. Find out what new changes to coding and reimbursement mean for providers and discover how SRT can fit into today's practice.Assessing the Role of Phototherapy in Psoriasis
https://practicaldermatology.com/topics/psoriasis/assessing-the-role-of-phototherapy-in-psoriasis/19887/Despite therapeutic advancements, phototherapy remains a beneficial treatment for many psoriasis patients. Henry Lim, MD summarizes his presentation from San Diego Dermatology Symposium, emphasizing safety and COVID-19 protocols.Re-opening and re-staffing: what to expect
https://practicaldermatology.com/topics/practice-management/re-opening-and-re-staffing-what-to-expect/19817/Reviving your dermatology practice is a team effort. You cannot do it without the support of your staff. This Ekwa Marketing video offers some tips to help navigate the logistics of staffing and keep everyone safe.Psoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of pDerm 2020: What’s New and in the Pipeline
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/derm-2020-whats-new-and-in-the-pipeline/19742/Michael Gold, MD shares insights on advances in aesthetic and medical dermatology, from novel devices to a new acne combination treatment being studied to skincare products, toxins and fillers coming to the US market.